CytomX Therapeutics
CTMX | NASDAQ
$1.94
-$0.05 (-2.27%)
At close: Nov 17, 2026, 4:00 PM ET
$2.03
+$0.09 (+4.64%)
After-hours:
Nov 17, 2026, 7:41 PM ET
CytomX Therapeutics Statistics
Key statistics explainedMarket Data
$422.93M
$79.34M
2.24
3.83M
219.11M
32.79%
97.56%
NASDAQ
US23284F1057
Price Performance
-14.9%
-42.8%
-46.7%
-54.5%
-47.0%
47.0%
-73.1%
-14.9%
-45.4%
-23.1%
-16.3%
Valuation
-4.31
N/A
N/A
N/A
30.15
13.50
1.48
-8.29
-6.76
-8.43
5.66
-1.22
-0.90
-1.56
-23.2%
-12.1%
-14.8%
Financial Health
$343.59M
$4.39M
$347.98M
$364.68M
7.82
7.82
0.02
-0.05
-0.09
-11.44
N/A
0.76
2
Margins & Profitability
98.2%
-676.5%
-624.0%
-609.0%
-363.6%
-446.3%
82.7%
-22.8%
Returns
-23.4%
-34.0%
-29.7%
-29.7%
-23.5%
Historical Growth (CAGR)
-47.1%
-26.7%
2.7%
-664.3%
82.8%
23.8%
26.7%
18.8%
-22.3%
Analyst Forecasts
Buy
8
5.9%
57.1%
Feb 24, 2027
-$0.08
-62.8%
$9.81M
1384.0%
Fair Value Estimates
N/A
N/A
N/A
N/A
$6.00
209.3%
Cash Flow
$-50.21M
$-51M
$-62.61M
-$0.23
-$0.23
-358.0%
Income Statement
$14.03M
$12.09M
$-94.89M
$-87.95M
$-85.42M
-$0.45
$203.29K
$-1.24M
69
Add to Watchlist
Select watchlists to add or remove CTMX